# NeuroPace Inc: filings

NPCE · Nasdaq · CIK 1528287 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/npce.md) · [Financials](/companies/npce/financials.md) · [Filings](/companies/npce/filings.md) · [Insiders](/companies/npce/insiders.md)

## Reports and events: 81 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 163, 8-K 50, 3 18, 10-Q 17, 144 11, SC 13G/A 11, SCHEDULE 13G/A 10, CORRESP 7, S-8 7, SC 13G 6, 10-K 5, DEF 14A 5, DEFA14A 5, 4/A 4, ARS 4, D 4, EFFECT 3, SCHEDULE 13G 3, 424B5 2, UPLOAD 2, 424B4 1, 8-A12B 1, CERT 1, D/A 1, DRS 1, FWP 1, POS AM 1, S-1 1, S-1/A 1, S-1MEF 1, S-3 1, SC 13D 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 16:33 ET | [10-Q](/filings/0001528287-26-000030.md) | Quarterly report, period 2026-06-30 | 0001528287-26-000030 |
| 2026-08-11 | 16:07 ET | [8-K](/filings/0001528287-26-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-26-000027 |
| 2026-07-28 | 16:31 ET | [8-K](/filings/0001193125-26-321083.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-321083 |
| 2026-06-08 | 16:54 ET | [8-K](/filings/0001193125-26-261965.md) | 5.07 Shareholder vote results | 0001193125-26-261965 |
| 2026-05-12 | 16:45 ET | [10-Q](/filings/0001528287-26-000022.md) | Quarterly report, period 2026-03-31 | 0001528287-26-000022 |
| 2026-05-12 | 16:07 ET | [8-K](/filings/0001528287-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-26-000019 |
| 2026-04-21 | 16:05 ET | [DEF 14A](/filings/0001140361-26-015894.md) | Proxy statement, period 2026-06-05 | 0001140361-26-015894 |
| 2026-03-03 | 16:54 ET | [10-K](/filings/0001528287-26-000011.md) | Annual report, period 2025-12-31 | 0001528287-26-000011 |
| 2026-03-03 | 16:09 ET | [8-K](/filings/0001528287-26-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-26-000008 |
| 2025-11-04 | 16:22 ET | [10-Q](/filings/0001528287-25-000032.md) | Quarterly report, period 2025-09-30 | 0001528287-25-000032 |
| 2025-11-04 | 16:10 ET | [8-K](/filings/0001528287-25-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-25-000030 |
| 2025-08-12 | 17:16 ET | [10-Q](/filings/0001528287-25-000022.md) | Quarterly report, period 2025-06-30 | 0001528287-25-000022 |
| 2025-08-12 | 16:08 ET | [8-K](/filings/0001528287-25-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-25-000021 |
| 2025-06-24 | 16:14 ET | [8-K](/filings/0001193125-25-145738.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-145738 |
| 2025-06-12 | 16:16 ET | [8-K](/filings/0001193125-25-139896.md) | 5.07 Shareholder vote results | 0001193125-25-139896 |
| 2025-06-04 | 16:35 ET | [8-K](/filings/0001193125-25-134946.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-134946 |
| 2025-05-27 | 08:09 ET | [8-K](/filings/0001193125-25-126268.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-126268 |
| 2025-05-13 | 17:15 ET | [10-Q](/filings/0001528287-25-000013.md) | Quarterly report, period 2025-03-31 | 0001528287-25-000013 |
| 2025-05-13 | 16:08 ET | [8-K](/filings/0001528287-25-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-25-000012 |
| 2025-04-22 | 16:00 ET | [DEF 14A](/filings/0001140361-25-014896.md) | Proxy statement, period 2025-06-06 | 0001140361-25-014896 |
| 2025-04-14 | 16:31 ET | [8-K](/filings/0001193125-25-080217.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-080217 |
| 2025-04-02 | 16:38 ET | [8-K](/filings/0001193125-25-071399.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-071399 |
| 2025-03-04 | 17:05 ET | [10-K](/filings/0001528287-25-000007.md) | Annual report, period 2024-12-31 | 0001528287-25-000007 |
| 2025-03-04 | 16:08 ET | [8-K](/filings/0001528287-25-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-25-000006 |
| 2025-02-20 | 16:15 ET | [8-K](/filings/0001193125-25-030729.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-030729 |
| 2025-02-18 | 08:00 ET | [8-K](/filings/0001193125-25-028174.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028174 |
| 2025-02-14 | 06:11 ET | [8-K](/filings/0001193125-25-026573.md) | 1.01 Entry into a material agreement | 0001193125-25-026573 |
| 2025-01-28 | 17:25 ET | [8-K](/filings/0001193125-25-014473.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-014473 |
| 2025-01-15 | 16:43 ET | [8-K](/filings/0001193125-25-007085.md) | 7.01 Regulation FD disclosure | 0001193125-25-007085 |
| 2025-01-08 | 16:38 ET | [8-K](/filings/0001193125-25-003547.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-003547 |
| 2024-11-12 | 17:15 ET | [10-Q](/filings/0001528287-24-000020.md) | Quarterly report, period 2024-09-30 | 0001528287-24-000020 |
| 2024-11-12 | 16:07 ET | [8-K](/filings/0001528287-24-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-24-000019 |
| 2024-08-13 | 17:14 ET | [10-Q](/filings/0001528287-24-000016.md) | Quarterly report, period 2024-06-30 | 0001528287-24-000016 |
| 2024-08-13 | 16:08 ET | [8-K](/filings/0001528287-24-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-24-000015 |
| 2024-06-10 | 17:30 ET | [8-K](/filings/0001193125-24-158459.md) | 5.07 Shareholder vote results | 0001193125-24-158459 |
| 2024-05-08 | 17:17 ET | [10-Q](/filings/0001528287-24-000011.md) | Quarterly report, period 2024-03-31 | 0001528287-24-000011 |
| 2024-05-08 | 16:16 ET | [8-K](/filings/0001528287-24-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-24-000010 |
| 2024-04-22 | 17:00 ET | [DEF 14A](/filings/0001140361-24-021062.md) | Proxy statement, period 2024-06-07 | 0001140361-24-021062 |
| 2024-03-05 | 17:00 ET | [10-K](/filings/0001528287-24-000005.md) | Annual report, period 2023-12-31 | 0001528287-24-000005 |
| 2024-03-05 | 16:11 ET | [8-K](/filings/0001528287-24-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-24-000004 |
| 2024-02-07 | 16:43 ET | [8-K](/filings/0001193125-24-026756.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-026756 |
| 2024-01-08 | 07:05 ET | [8-K](/filings/0001193125-24-003861.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-003861 |
| 2023-12-04 | 17:01 ET | [8-K](/filings/0001193125-23-288474.md) | 1.01 Entry into a material agreement | 0001193125-23-288474 |
| 2023-11-06 | 16:55 ET | [10-Q](/filings/0001528287-23-000041.md) | Quarterly report, period 2023-09-30 | 0001528287-23-000041 |
| 2023-11-06 | 16:15 ET | [8-K](/filings/0001528287-23-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-23-000040 |
| 2023-08-08 | 16:56 ET | [10-Q](/filings/0001528287-23-000034.md) | Quarterly report, period 2023-06-30 | 0001528287-23-000034 |
| 2023-08-08 | 16:09 ET | [8-K](/filings/0001528287-23-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001528287-23-000033 |
| 2023-07-19 | 16:01 ET | [8-K](/filings/0001193125-23-189608.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-189608 |
| 2023-06-28 | 16:06 ET | [8-K](/filings/0001193125-23-177492.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-177492 |
| 2023-06-12 | 16:14 ET | [8-K](/filings/0001528287-23-000028.md) | 5.07 Shareholder vote results | 0001528287-23-000028 |

Page 1 of 2. [Older](/companies/npce/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.